We are successfully investing the operational excess in promising helathcare and biotech companies.

Through fundamental analysis using value investing approach, we understand how a business works:

From development of the molecule to marketing approval and launch in order to get a fair value of the company.

You benefit from the fact that we not only know the trends and markets in the international pharma business but also understand the key figures and setting screws that make a company successful.

With this we can take the right strategies and measures necessary to gain a competitive edge over competitors.